The IDEAL trial - a study protocol for a phase III randomized, double-blinded clinical trial assessing the ultra-short antibiotic prophylaxis of Isoniazid and Rifapentine in non-immunosuppressed patients with newly diagnosed latent tuberculosis. Principles and Practice of Clinical Research, [S. l.], v. 6, n. 1, p. 9–14, 2020. Disponível em: https://journal.ppcr.org/index.php/ppcrjournal/article/view/96.. Acesso em: 14 apr. 2025.